NCT01219556View on ClinicalTrials.gov

Xirtam H Combination In the Treatment of Hypertension Evaluation Study.

CompletedOBSERVATIONAL

Enrollment

8,704

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

January 31, 2012

Study Completion Date

February 28, 2013

Conditions

Hypertension

Interventions

DRUG

Olmesartan plus hydrochlorothiazide (Xirtam H, BAY98-7105)

Oral Xirtam H tablets every 24 hours (Q24H) or as per prescribing information

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY